“…Our recent studies have been focused on the study of divalent Co(II), Ni(II), Cu(II) or Zn(II) complexes with antimicrobial [10,[43][44][45][46][47][48][49][50] or antiinflammatory drugs [17,18,[51][52][53] in the absence or presence of N-donor(s) heterocyclic ligands. Taking into consideration the significance of the quinolones in medicine [1][2][3][4] and the fact that metal complexes with drugs may exhibit more pronounced biological properties in comparison to the free drugs, we have initiated the interaction of Cu(II) with quinolones [15,16,29,33,[36][37][38].…”